Research Paper Volume 15, Issue 18 pp 9809—9821
The oncogenic miR-429 promotes triple-negative breast cancer progression by degrading DLC1
Figure 1. The tumorigenic feature of miR-429 in TNBC. (A) the miR-429 relative expression in normal (n=102) and TNBC tissues (n=63). (B) Kaplan-Meier curve analysis of OS in patients with TNBC (Blue: reduced expression; Red: enhanced expression). (C) miR-429 relative expression in MCF-10A and MDA-MB-468 cells. Scale bar = 50 μm. TNBC: triple-negative breast cancer; OS: overall survival. (* p < 0.05, ** p < 0.01, and *** p < 0.001).